Otsuka Holdings
4578.T
#661
Rank
โ‚น3.574 T
Marketcap
โ‚น6,779
Share price
-1.58%
Change (1 day)
57.17%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: โ‚น99.74 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น99.74 Billion a decrease over its 2022 earnings that were of โ‚น126.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023โ‚น99.74 B-20.93%
2022โ‚น126.14 B-12.7%
2021โ‚น144.49 B-19.92%
2020โ‚น180.44 B13.9%
2019โ‚น158.43 B52.07%
2018โ‚น104.18 B11.22%
2017โ‚น93.67 B-36.03%
2016โ‚น146.42 B31.15%
2015โ‚น111.64 B
2013โ‚น231.73 B33.52%
2012โ‚น173.56 B-4.65%
2011โ‚น182.02 B45.53%
2010โ‚น125.08 B